{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:04:27Z","timestamp":1775581467028,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31871167"],"award-info":[{"award-number":["31871167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01300-3","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:05:44Z","timestamp":1772035544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perivascular spread of CSF-derived \u03b1-synuclein oligomers drives region-specific Parkinson\u2019s-like pathology"],"prefix":"10.1038","volume":"12","author":[{"given":"Wen-Xin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Zhong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Cai","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Xuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Ru","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"1300_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"1300_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3988\/jcn.2011.7.4.215","volume":"7","author":"MJ Park","year":"2011","unstructured":"Park, M. J., Cheon, S. M., Bae, H. R., Kim, S. H. & Kim, J. W. Elevated levels of \u03b1-synuclein oligomer in the cerebrospinal fluid of drug-na\u00efve patients with Parkinson\u2019s disease. J. Clin. Neurol. 7, 215\u2013222 (2011).","journal-title":"J. Clin. Neurol."},{"key":"1300_CR3","doi-asserted-by":"publisher","first-page":"121ra120","DOI":"10.1126\/scitranslmed.3002566","volume":"4","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. Phosphorylated \u03b1-synuclein in Parkinson\u2019s disease. Sci. Transl. Med 4, 121ra120 (2012).","journal-title":"Sci. Transl. Med"},{"key":"1300_CR4","doi-asserted-by":"crossref","unstructured":"Srinivasan, E. et al. Alpha-synuclein aggregation in Parkinson\u2019s disease. Front. Med. 8, 736978 (2021).","DOI":"10.3389\/fmed.2021.736978"},{"key":"1300_CR5","doi-asserted-by":"crossref","unstructured":"Emin, D. et al. Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease. Nat. Commun. 13, 5512 (2022).","DOI":"10.1038\/s41467-022-33252-6"},{"key":"1300_CR6","doi-asserted-by":"crossref","unstructured":"Kapsali, I., Brinia, M. E. & Constantinides, V. C. Cerebrospinal fluid total, phosphorylated and oligomeric a-synuclein in Parkinson\u2019s disease: a systematic review, meta-analysis and meta-regression study. Biomedicines 12, 2266 (2024).","DOI":"10.3390\/biomedicines12102266"},{"key":"1300_CR7","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3233\/JPD-202141","volume":"10","author":"M von Euler Chelpin","year":"2020","unstructured":"von Euler Chelpin, M. et al. Alpha-synuclein protofibrils in cerebrospinal fluid: a potential biomarker for Parkinson\u2019s disease. J. Parkinsons Dis. 10, 1429\u20131442 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"1300_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/nan.12524","volume":"45","author":"H Ning","year":"2019","unstructured":"Ning, H. et al. Baseline concentration of misfolded \u03b1-synuclein aggregates in cerebrospinal fluid predicts risk of cognitive decline in Parkinson\u2019s disease. Neuropathol. Appl Neurobiol. 45, 398\u2013409 (2019).","journal-title":"Neuropathol. Appl Neurobiol."},{"key":"1300_CR9","doi-asserted-by":"crossref","unstructured":"Ganguly, U. et al. Alpha-synuclein as a biomarker of Parkinson\u2019s disease: good, but not good enough. Front. Aging Neurosci. 13, 702639 (2021).","DOI":"10.3389\/fnagi.2021.702639"},{"key":"1300_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bbr.2017.06.047","volume":"333","author":"JTS Fortuna","year":"2017","unstructured":"Fortuna, J. T. S. et al. Brain infusion of \u03b1-synuclein oligomers induces motor and non-motor Parkinson\u2019s disease-like symptoms in mice. Behav. Brain Res. 333, 150\u2013160 (2017).","journal-title":"Behav. Brain Res."},{"key":"1300_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1471-4159.2011.07576.x","volume":"120","author":"ZS Martin","year":"2012","unstructured":"Martin, Z. S. et al. a-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases. J. Neurochem. 120, 440\u2013452 (2012).","journal-title":"J. Neurochem."},{"key":"1300_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.bbi.2018.02.012","volume":"69","author":"P La Vitola","year":"2018","unstructured":"La Vitola, P. et al. Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2. Brain Behav. Immun. 69, 591\u2013602 (2018).","journal-title":"Brain Behav. Immun."},{"key":"1300_CR13","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1523\/JNEUROSCI.0619-21.2021","volume":"41","author":"LM Hablitz","year":"2021","unstructured":"Hablitz, L. M. & Nedergaard, M. The Glymphatic System: A Novel Component of Fundamental Neurobiology. J. Neurosci. 41, 7698\u20137711 (2021).","journal-title":"J. Neurosci."},{"key":"1300_CR14","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci. Transl. Med. 4, 147ra111 (2012).","journal-title":"Sci. Transl. Med."},{"key":"1300_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abb8739","volume":"370","author":"M Nedergaard","year":"2020","unstructured":"Nedergaard, M. & Goldman, S. A. Glymphatic failure as a final common pathway to dementia. Science 370, 50\u201356 (2020).","journal-title":"Science"},{"key":"1300_CR16","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41593-023-01441-1","volume":"26","author":"S Holstein-Ronsbo","year":"2023","unstructured":"Holstein-Ronsbo, S. et al. Glymphatic influx and clearance are accelerated by neurovascular coupling (vol 26, pg 1042, 2023). Nat. Neurosci. 26, 2036\u20132036 (2023).","journal-title":"Nat. Neurosci."},{"key":"1300_CR17","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.4103\/1673-5374.390970","volume":"19","author":"Y Yue","year":"2024","unstructured":"Yue, Y., Zhang, X., Lv, W., Lai, H. Y. & Shen, T. Interplay between the glymphatic system and neurotoxic proteins in Parkinson\u2019s disease and related disorders: current knowledge and future directions. Neural Regen. Res 19, 1973\u20131980 (2024).","journal-title":"Neural Regen. Res"},{"key":"1300_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf029","volume":"7","author":"Y Zhao","year":"2025","unstructured":"Zhao, Y. et al. Glymphatic dysfunction exacerbates cognitive decline by triggering cortical degeneration in Parkinson\u2019s disease: evidence from diffusion-tensor MRI. Brain Commun. 7, fcaf029 (2025).","journal-title":"Brain Commun."},{"key":"1300_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-016-0138-8","volume":"11","author":"TM Achariyar","year":"2016","unstructured":"Achariyar, T. M. et al. Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation. Mol. Neurodegener. 11, 74 (2016).","journal-title":"Mol. Neurodegener."},{"key":"1300_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbd.2016.05.015","volume":"93","author":"W Peng","year":"2016","unstructured":"Peng, W. et al. Suppression of glymphatic fluid transport in a mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 93, 215\u2013225 (2016).","journal-title":"Neurobiol. Dis."},{"key":"1300_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"1300_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier, D. J., Obeso, J. A. & Halliday, G. M. Selective neuronal vulnerability in Parkinson disease. Nat. Rev. Neurosci. 18, 101\u2013113 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"1300_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00702-011-0641-6","volume":"118","author":"G Halliday","year":"2011","unstructured":"Halliday, G., Song, Y. & Harding, A. Striatal \u03b2-amyloid in dementia with Lewy bodies but not Parkinson\u2019s disease. J. Neural Transm. 118, 713\u2013719 (2011).","journal-title":"J. Neural Transm."},{"key":"1300_CR24","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s12035-023-03212-2","volume":"60","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Interaction between the glymphatic system and \u03b1-synuclein in Parkinson\u2019s disease. Mol. Neurobiol. 60, 2209\u20132222 (2023).","journal-title":"Mol. Neurobiol."},{"key":"1300_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41586-019-1419-5","volume":"572","author":"JH Ahn","year":"2019","unstructured":"Ahn, J. H. et al. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature 572, 62\u201366 (2019).","journal-title":"Nature"},{"key":"1300_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41591-020-01198-1","volume":"27","author":"XB Ding","year":"2021","unstructured":"Ding, X. B. et al. Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson\u2019s disease. Nat. Med 27, 411\u2013418 (2021).","journal-title":"Nat. Med"},{"key":"1300_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104558","volume":"91","author":"I Spera","year":"2023","unstructured":"Spera, I. et al. Open pathways for cerebrospinal fluid outflow at the cribriform plate along the olfactory nerves. EBioMedicine 91, 104558 (2023).","journal-title":"EBioMedicine"},{"key":"1300_CR28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2990.2006.00737.x","volume":"32","author":"BA Walter","year":"2006","unstructured":"Walter, B. A., Valera, V. A., Takahashi, S. & Ushiki, T. The olfactory route for cerebrospinal fluid drainage into the peripheral lymphatic system. Neuropathol. Appl Neurobiol. 32, 388\u2013396 (2006).","journal-title":"Neuropathol. Appl Neurobiol."},{"key":"1300_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12987-020-00233-0","volume":"17","author":"M Brady","year":"2020","unstructured":"Brady, M. et al. Cerebrospinal fluid drainage kinetics across the cribriform plate are reduced with aging. Fluids Barriers CNS 17, 71 (2020).","journal-title":"Fluids Barriers CNS"},{"key":"1300_CR30","doi-asserted-by":"crossref","unstructured":"Mestre, H. et al. Aquaporin-4-dependent glymphatic solute transport in the rodent brain. Elife 7, e40070 (2018).","DOI":"10.7554\/eLife.40070"},{"key":"1300_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.lfs.2017.05.028","volume":"182","author":"F Wei","year":"2017","unstructured":"Wei, F. et al. The pathway of subarachnoid CSF moving into the spinal parenchyma and the role of astrocytic aquaporin-4 in this process. Life Sci. 182, 29\u201340 (2017).","journal-title":"Life Sci."},{"key":"1300_CR32","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/brain\/awaa179","volume":"143","author":"IF Harrison","year":"2020","unstructured":"Harrison, I. F. et al. Impaired glymphatic function and clearance of tau in an Alzheimer\u2019s disease model. Brain 143, 2576\u20132593 (2020).","journal-title":"Brain"},{"key":"1300_CR33","doi-asserted-by":"crossref","unstructured":"Chen, Y. N. & Kostka, J. K. Beyond anosmia: olfactory dysfunction as a common denominator in neurodegenerative and neurodevelopmental disorders. Front. Neurosci. 18, 1502779 (2024).","DOI":"10.3389\/fnins.2024.1502779"},{"key":"1300_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-002-1301-4","volume":"249","author":"H Braak","year":"2002","unstructured":"Braak, H. et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages). J. Neurol. 249, 1\u20135 (2002).","journal-title":"J. Neurol."},{"key":"1300_CR35","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach, T. G. et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol. 117, 613\u2013634 (2009).","journal-title":"Acta Neuropathol."},{"key":"1300_CR36","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1177\/0271678X221109997","volume":"42","author":"XZ He","year":"2022","unstructured":"He, X. Z. et al. High-resolution 3D demonstration of regional heterogeneity in the glymphatic system. J. Cereb. Blood Flow. Metab. 42, 2017\u20132031 (2022).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1300_CR37","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1016\/j.celrep.2019.02.050","volume":"26","author":"AS Munk","year":"2019","unstructured":"Munk, A. S. et al. PDGF-B is required for development of the glymphatic system. Cell Rep. 26, 2955\u20132969 e2953 (2019).","journal-title":"Cell Rep."},{"key":"1300_CR38","doi-asserted-by":"crossref","unstructured":"Hubbard, J. A., Hsu, M. S., Seldin, M. M. & Binder, D. K. Expression of the astrocyte water channel aquaporin-4 in the mouse brain. ASN Neuro. 7, 1759091415605486 (2015).","DOI":"10.1177\/1759091415605486"},{"key":"1300_CR39","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci. Transl. Med. 4, 147ra111 (2012).","journal-title":"Sci. Transl. Med."},{"key":"1300_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-107","volume":"11","author":"L Yang","year":"2013","unstructured":"Yang, L. et al. Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer. J. Transl. Med. 11, 107 (2013).","journal-title":"J. Transl. Med."},{"key":"1300_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.lfs.2018.03.057","volume":"201","author":"C Zhang","year":"2018","unstructured":"Zhang, C. et al. Characterizing the glymphatic influx by utilizing intracisternal infusion of fluorescently conjugated cadaverine. Life Sci. 201, 150\u2013160 (2018).","journal-title":"Life Sci."},{"key":"1300_CR42","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/glia.20990","volume":"58","author":"TM Mathiisen","year":"2010","unstructured":"Mathiisen, T. M., Lehre, K. P., Danbolt, N. C. & Ottersen, O. P. The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 58, 1094\u20131103 (2010).","journal-title":"Glia"},{"key":"1300_CR43","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1128\/jb.107.3.718-735.1971","volume":"107","author":"R Scherrer","year":"1971","unstructured":"Scherrer, R. & Gerhardt, P. Molecular sieving by the Bacillus megaterium cell wall and protoplast. J. Bacteriol. 107, 718\u2013735 (1971).","journal-title":"J. Bacteriol."},{"key":"1300_CR44","doi-asserted-by":"publisher","first-page":"13565","DOI":"10.1021\/la8028403","volume":"24","author":"LM Dominak","year":"2008","unstructured":"Dominak, L. M. & Keating, C. D. Macromolecular crowding improves polymer encapsulation within giant lipid vesicles. Langmuir 24, 13565\u201313571 (2008).","journal-title":"Langmuir"},{"key":"1300_CR45","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1529\/biophysj.104.047746","volume":"87","author":"JK Armstrong","year":"2004","unstructured":"Armstrong, J. K., Wenby, R. B., Meiselman, H. J. & Fisher, T. C. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys. J. 87, 4259\u20134270 (2004).","journal-title":"Biophys. J."},{"key":"1300_CR46","first-page":"E1994","volume":"112","author":"SW Chen","year":"2015","unstructured":"Chen, S. W. et al. Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation. Proc. Natl. Acad. Sci. USA 112, E1994\u20132003 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1300_CR47","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","volume":"25","author":"C Pacelli","year":"2015","unstructured":"Pacelli, C. et al. Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons. Curr. Biol. 25, 2349\u20132360 (2015).","journal-title":"Curr. Biol."},{"key":"1300_CR48","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1016\/j.neurobiolaging.2013.06.006","volume":"34","author":"K Melachroinou","year":"2013","unstructured":"Melachroinou, K. et al. Deregulation of calcium homeostasis mediates secreted \u03b1-synuclein-induced neurotoxicity. Neurobiol. Aging 34, 2853\u20132865 (2013).","journal-title":"Neurobiol. Aging"},{"key":"1300_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF01257970","volume":"10","author":"N Hal\u00e1sz","year":"1981","unstructured":"Hal\u00e1sz, N., Johansson, O., H\u00f6kfelt, T., Ljungdahl, A. & Goldstein, M. Immunohistochemical identification of two types of dopamine neuron in the rat olfactory bulb as seen by serial sectioning. J. Neurocytol. 10, 251\u2013259 (1981).","journal-title":"J. Neurocytol."},{"key":"1300_CR50","doi-asserted-by":"crossref","unstructured":"Schreiner, T. G., Men\u00e9ndez-Gonz\u00e1lez, M. & Popescu, B. O. The \u201cCerebrospinal Fluid Sink Therapeutic Strategy\u201d in Alzheimer\u2019s disease-from theory to design of applied systems. Biomedicines 10, 1509 (2022).","DOI":"10.3390\/biomedicines10071509"},{"key":"1300_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/17434440.2023.2181695","volume":"20","author":"MM Gonz\u00e1lez","year":"2023","unstructured":"Gonz\u00e1lez, M. M. Mechanical filtration of the cerebrospinal fluid: procedures, systems, and applications. Expert Rev. Med. Devices 20, 199\u2013207 (2023).","journal-title":"Expert Rev. Med. Devices"},{"key":"1300_CR52","doi-asserted-by":"crossref","unstructured":"Menendez-Gonzalez, M. et al. Targeting beta-amyloid at the CSF: a new therapeutic strategy in Alzheimer\u2019s disease. Front. Aging Neurosci. 10, 100 (2018).","DOI":"10.3389\/fnagi.2018.00100"},{"key":"1300_CR53","doi-asserted-by":"crossref","unstructured":"Coto-Vilcapoma, M. A. et al. New, fully implantable device for selective clearance of CSF-target molecules: proof of concept in a murine model of Alzheimer\u2019s disease. Int. J. Mol. Sci. 23, 9256 (2022).","DOI":"10.3390\/ijms23169256"},{"key":"1300_CR54","doi-asserted-by":"publisher","first-page":"fcaf304","DOI":"10.1093\/braincomms\/fcaf304","volume":"7","author":"C Shering","year":"2025","unstructured":"Shering, C. et al. Phase 1, randomized trials of MEDI1341: cerebrospinal fluid free \u03b1-synuclein lowered by >50. Brain Commun. 7, fcaf304 (2025).","journal-title":"Brain Commun."},{"key":"1300_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00415-024-12770-x","volume":"272","author":"M Alfaidi","year":"2024","unstructured":"Alfaidi, M., Barker, R. A. & Kuan, W. L. An update on immune-based alpha-synuclein trials in Parkinson\u2019s disease. J. Neurol. 272, 21 (2024).","journal-title":"J. Neurol."},{"key":"1300_CR56","doi-asserted-by":"crossref","unstructured":"Men\u00e9ndez-Gonz\u00e1lez, M., Padilla-Zambrano, H. S., Tom\u00e1s-Zapico, C. & Garc\u00eda, B. F. Clearing extracellular alpha-synuclein from cerebrospinal fluid: a new therapeutic strategy in Parkinson\u2019s disease. Brain Sci. 8, 52 (2018).","DOI":"10.3390\/brainsci8040052"},{"key":"1300_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40035-020-00192-4","volume":"9","author":"NK Majbour","year":"2020","unstructured":"Majbour, N. K. et al. CSF total and oligomeric \u03b1-Synuclein along with TNF-\u03b1 as risk biomarkers for Parkinson\u2019s disease: a study in LRRK2 mutation carriers. Transl. Neurodegener. 9, 15 (2020).","journal-title":"Transl. Neurodegener."},{"key":"1300_CR58","doi-asserted-by":"crossref","unstructured":"Mishra, P. S. et al. Transmission of ALS pathogenesis by the cerebrospinal fluid. Acta Neuropathol. Commun. 8, 65 (2020).","DOI":"10.1186\/s40478-020-00943-4"},{"key":"1300_CR59","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1177\/0271678X20924954","volume":"40","author":"NB B\u00e8chet","year":"2020","unstructured":"B\u00e8chet, N. B. et al. Light sheet fluorescence microscopy of optically cleared brains for studying the glymphatic system. J. Cereb. Blood Flow. Metab. 40, 1975\u20131986 (2020).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1300_CR60","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s12264-020-00548-w","volume":"36","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Quantitative Determination of Glymphatic Flow Using Spectrophotofluorometry. Neurosci. Bull. 36, 1524\u20131537 (2020).","journal-title":"Neurosci. Bull."},{"key":"1300_CR61","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.2897","volume":"8","author":"CF Machado","year":"2018","unstructured":"Machado, C. F., Reis-Silva, T. M., Lyra, C. S., Felicio, L. F. & Malnic, B. Buried Food-seeking Test for the Assessment of Olfactory Detection in Mice. Bio Protoc. 8, e2897 (2018).","journal-title":"Bio Protoc."},{"key":"1300_CR62","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/brain\/awz380","volume":"143","author":"T Taguchi","year":"2020","unstructured":"Taguchi, T. et al. \u03b1-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson\u2019s disease model. Brain 143, 249\u2013265 (2020).","journal-title":"Brain"},{"key":"1300_CR63","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14587","volume":"30","author":"J Song","year":"2024","unstructured":"Song, J. et al. Neonatal stress disrupts the glymphatic system development and increases the susceptibility to Parkinson\u2019s disease in later life. CNS Neurosci. Ther. 30, e14587 (2024).","journal-title":"CNS Neurosci. Ther."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01300-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01300-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01300-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:02:48Z","timestamp":1775577768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01300-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1300"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01300-3","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}